PATRICIA MELVILLE: Open Payments
NPI 1033440896 · EAST SETAUKET, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$87,360 in 139 payments from 13 companies in 2025. Trend: 2023 $59,863 · 2024 $58,839 · 2025 $87,360
Speaker / faculty: $49,978Consulting: $18,848Travel & lodging: $14,698Food & beverage: $3,837
| Company | Payments | Amount |
|---|---|---|
| TG Therapeutics, Inc. | 35 | $30,738 |
| Genentech USA, Inc. | 34 | $25,057 |
| Amgen Inc. | 29 | $21,495 |
| Novartis Pharmaceuticals Corporation | 9 | $5,844 |
| E.R. Squibb & Sons, L.L.C. | 6 | $3,161 |
| EMD Serono, Inc. | 4 | $422 |
| ABBVIE INC. | 12 | $193 |
| Biogen, Inc. | 2 | $180 |
| ARGENX US, INC. | 1 | $125 |
| Lundbeck LLC | 3 | $62 |
Products named: BRIUMVI, Ocrevus, UPLIZNA, KESIMPTA, ZEPOSIA, VUMERITY, VYVGART, Mavenclad.
Industry payments across NY — which companies pay providers there.
